All results
11 results for lifestyle study
-
Fasting ENHANCE
Grounded in the principles of geroscience, the proposed Fasting ENHANCE study will test whether a time restricted eating (TRE) regimen can improve cognitive…
- Ages
- 65 Years - N/A
- Sexes
- All
-
RIN-PF-302
Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis. Study…
- Ages
- 40 Years - N/A
- Sexes
- All
-
Terrain Variation Study
Modern footwear has been implicated as a contributor to foot pathology and changes in the biomechanics of gait. In addition to footwear, the investigators…
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
TETON
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from…
- Ages
- 40 Years - N/A
- Sexes
- All
-
Teton RIN-PF-301
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from…
- Ages
- 40 Years - N/A
- Sexes
- All
-
Givinostat Long Term Study
This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been…
- Ages
- 7 Years - N/A
- Sexes
- Male
-
TAK-999-3003
The main aim of this study is to learn if fazirsiran is safe during long-term use in people with liver disease caused by the abnormal Z-alpha-1 antitrypsin…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Comprehensive Outcomes for After Cancer Health (COACH)
This study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Testing Triapine w/ Targeted Radiation-based LU177 vs Lu177 alone in pts w/ metastatic NETs
This phase II trial compares the effect of adding triapine to lutetium Lu 177 dotatate versus lutetium Lu 177 dotatate alone (standard therapy) in shrinking…
- Ages
- 18 Years - N/A
- Sexes
- All
-
GCAptAIN
This is a phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with giant cell…
- Ages
- 50 Years - N/A
- Sexes
- All